Work

A phase Ib trial of enzalutamide with oral decitabine/cedazuridine in metastatic castration-resistant prostate cancer (CRPC).

Year: 2024

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2024.42.4_suppl.tps252

Authors: Arya Mariam Roy, Dharmesh Gopalakrishnan, Karan Jatwani, Kelly Green, Bailey Farmer, Neha Jaiswal, Kristopher Attwood, Ellis Glenn Levine, Himisha Beltran, David Goodrich, Gurkamal S. Chatta

Institutions: Roswell Park Comprehensive Cancer Center, Dana-Farber Cancer Institute

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4391303133

Cites:

Cited by:

Related to: 10